HealthcarePress Releases

Esoteric Testing Market Size to Worth Around US$ 67.39 Billion by 2030

The global esoteric testing market size is expected to reach USD 67.39 Billion by 2030, with a CAGR of 11.19% from 2022 to 2030.

[150+ Pages Report] As per the latest Research and survey report issued by Precedence Research, the global esoteric testing market was valued at around USD 25.94 billion in 2021 and is expected to register revenues worth USD 67.39 billion by the end of 2030, growing at an exceptional CAGR of approximately 11.19% between 2022 and 2030.

Esoteric Testing Market

Download Free Sample Copy with TOC@ https://www.precedenceresearch.com/sample/2019

Esoteric Testing Market Report Scope

A recent study by Precedence Research on the esoteric testing market offers a forecast for 2022 and 2030. The study analyzes crucial trends that are currently determining the growth of the esoteric testing market. This report explicates on vital dynamics such as the drivers, restraints, and opportunities for key market players, along with key stakeholders as well as emerging players associated with the manufacturing of esoteric testing. The study also provides the dynamics that are responsible for influencing the future status of the esoteric testing market over the forecast period.

A detailed assessment of the esoteric testing market value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report. A list of prominent companies operating in the esoteric testing market along with their product portfolio enhances the reliability of this comprehensive research study.

Competition Landscape

The report has engulfed a chapter on the global esoteric testing market’s competitive landscape, which provides detailed analysis and insights on companies offering esoteric testing. Profiles of key companies, along with a strategic overview of their M&A and expansion plans across geographies, have been delivered in this chapter. This chapter is priceless for report readers, as its enables them in gauging their growth potential in the market and implement key strategies for extending their market reach.

This chapter offers key recommendations for both new and existing market participants, enabling them to emerge sustainably and profitably. Intelligence on the market players has been delivered on the basis of their product overview, SWOT analysis, key developments, key financials and company overview. Occupancy of these market participants has been tracked by the report and portrayed via an intensity map.

Read Also@ Machine Condition Monitoring Market Size to Worth Around US$ 7.45 Billion by 2030

Some of the Prominent Players in the Esoteric Testing Market Include:
  • ACM Global Laboratories (US)
  • ARUP Laboratories (US).
  • Baylor Esoteric and Molecular Laboratory (US)
  • BioAgilytix Labs (US)
  • BP Diagnostic Centre SDN BHD (Malaysia)
  • BUHLMANN Diagnostics Corp (BDC, US)
  • Cerba Xpert (Belgium)
  • Eurofins Scientific (Luxembourg)
  • Flow Health (US)
  • Foundation Medicine (US)
  • Georgia Esoteric & Molecular Laboratory, LLC (US)
  • H.U. Group Holdings, Inc. (Japan)
  • Helius Limited (Australia)
  • HealthQuest Esoterics (US)
  • Kind star Global (Beijing) Technology, Inc. (China)
  • Labcorp (US)
  • Leo Labs, Inc. (India).
  • Mayo Foundation for Medical Education and Research (US)
  • National Medical Services Inc. (NMS) (US)
  • OPKO Health (US).
  • Quest Diagnostics (US
  • Sonic Healthcare Limited (US)
  • Stanford Clinical Pathology (US)
  • Thyrocare Technologies Ltd. (India)
Esoteric Testing Market Segmentation

By Type

  • Infectious Diseases Testing
  • Endocrinology Testing
  • Oncology Testing
  • Genetics Testing
  • Toxicology Testing
  • Immunology Testing
  • Neurology Testing
  • Other Testing

By Technology

  • Chemiluminescence Immunoassay
  • Enzyme-Linked Immunosorbent Assay
  • Mass Spectrometry
  • Real-Time PCR
  • DNA Sequencing
  • Flow Cytometry
  • Other Technologies

By End User

  • Independent & Reference Laboratories
  • Hospital-Based Laboratories

Regional Segmentation

  • Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia]
  • Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
  • North America [United States, Canada, Mexico]
  • South America [Brazil, Argentina, Columbia, Chile, Peru]
  • Middle East & Africa [GCC, North Africa, South Africa]

Regional Analysis

The research report includes a detailed study of regions of North America, Europe, China, Japan and Rest of the World. The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2022 to 2030. These analyses will help the reader to understand the potential worth of investment in a particular region.

The report provides in-depth segment analysis of the global esoteric testing market, thereby providing valuable insights at macro as well as micro levels. Analysis of major countries, which hold growth opportunities or account for significant share has also been included as part of geographic analysis of the esoteric testing market.

The report includes country-wise and region-wise market size for the period 2022-2030. It also includes market size and forecast by segments in terms of production capacity, price and revenue for the period 2022-2030.

Why should you invest in this report?

If you are aiming to enter the global esoteric testing market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for esoteric testing are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2022-2030 so that you can plan your strategies to enter this market accordingly.

Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.

Table of Contents

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Esoteric Testing Market 

5.1. COVID-19 Landscape: Esoteric Testing Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Esoteric Testing Market, By Type

8.1. Esoteric Testing Market, by Type, 2022-2030

8.1.1 Infectious Diseases Testing

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Endocrinology Testing

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Oncology Testing

8.1.3.1. Market Revenue and Forecast (2017-2030)

8.1.4. Genetics Testing

8.1.4.1. Market Revenue and Forecast (2017-2030)

8.1.5. Toxicology Testing

8.1.5.1. Market Revenue and Forecast (2017-2030)

8.1.6. Immunology Testing

8.1.6.1. Market Revenue and Forecast (2017-2030)

8.1.7. Neurology Testing

8.1.7.1. Market Revenue and Forecast (2017-2030)

8.1.8. Other Testing

8.1.8.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Esoteric Testing Market, By Technology

9.1. Esoteric Testing Market, by Technology, 2022-2030

9.1.1. Chemiluminescence Immunoassay

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Enzyme-Linked Immunosorbent Assay

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Mass Spectrometry

9.1.3.1. Market Revenue and Forecast (2017-2030)

9.1.4. Real-Time PCR

9.1.4.1. Market Revenue and Forecast (2017-2030)

9.1.5. DNA Sequencing

9.1.5.1. Market Revenue and Forecast (2017-2030)

9.1.6. Flow Cytometry

9.1.6.1. Market Revenue and Forecast (2017-2030)

9.1.7. Other Technologies

9.1.7.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Esoteric Testing Market, By End User 

10.1. Esoteric Testing Market, by End User, 2022-2030

10.1.1. Independent & Reference Laboratories

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Hospital-Based Laboratories

10.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Esoteric Testing Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Type (2017-2030)

11.1.2. Market Revenue and Forecast, by Technology (2017-2030)

11.1.3. Market Revenue and Forecast, by End User (2017-2030)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Type (2017-2030)

11.1.4.2. Market Revenue and Forecast, by Technology (2017-2030)

11.1.4.3. Market Revenue and Forecast, by End User (2017-2030)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Type (2017-2030)

11.1.5.2. Market Revenue and Forecast, by Technology (2017-2030)

11.1.5.3. Market Revenue and Forecast, by End User (2017-2030)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Type (2017-2030)

11.2.2. Market Revenue and Forecast, by Technology (2017-2030)

11.2.3. Market Revenue and Forecast, by End User (2017-2030)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Type (2017-2030)

11.2.4.2. Market Revenue and Forecast, by Technology (2017-2030)

11.2.4.3. Market Revenue and Forecast, by End User (2017-2030)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Type (2017-2030)

11.2.5.2. Market Revenue and Forecast, by Technology (2017-2030)

11.2.5.3. Market Revenue and Forecast, by End User (2017-2030)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Type (2017-2030)

11.2.6.2. Market Revenue and Forecast, by Technology (2017-2030)

11.2.6.3. Market Revenue and Forecast, by End User (2017-2030)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Type (2017-2030)

11.2.7.2. Market Revenue and Forecast, by Technology (2017-2030)

11.2.7.3. Market Revenue and Forecast, by End User (2017-2030)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Type (2017-2030)

11.3.2. Market Revenue and Forecast, by Technology (2017-2030)

11.3.3. Market Revenue and Forecast, by End User (2017-2030)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Type (2017-2030)

11.3.4.2. Market Revenue and Forecast, by Technology (2017-2030)

11.3.4.3. Market Revenue and Forecast, by End User (2017-2030)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Type (2017-2030)

11.3.5.2. Market Revenue and Forecast, by Technology (2017-2030)

11.3.5.3. Market Revenue and Forecast, by End User (2017-2030)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Type (2017-2030)

11.3.6.2. Market Revenue and Forecast, by Technology (2017-2030)

11.3.6.3. Market Revenue and Forecast, by End User (2017-2030)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Type (2017-2030)

11.3.7.2. Market Revenue and Forecast, by Technology (2017-2030)

11.3.7.3. Market Revenue and Forecast, by End User (2017-2030)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Type (2017-2030)

11.4.2. Market Revenue and Forecast, by Technology (2017-2030)

11.4.3. Market Revenue and Forecast, by End User (2017-2030)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Type (2017-2030)

11.4.4.2. Market Revenue and Forecast, by Technology (2017-2030)

11.4.4.3. Market Revenue and Forecast, by End User (2017-2030)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Type (2017-2030)

11.4.5.2. Market Revenue and Forecast, by Technology (2017-2030)

11.4.5.3. Market Revenue and Forecast, by End User (2017-2030)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Type (2017-2030)

11.4.6.2. Market Revenue and Forecast, by Technology (2017-2030)

11.4.6.3. Market Revenue and Forecast, by End User (2017-2030)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Type (2017-2030)

11.4.7.2. Market Revenue and Forecast, by Technology (2017-2030)

11.4.7.3. Market Revenue and Forecast, by End User (2017-2030)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Type (2017-2030)

11.5.2. Market Revenue and Forecast, by Technology (2017-2030)

11.5.3. Market Revenue and Forecast, by End User (2017-2030)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Type (2017-2030)

11.5.4.2. Market Revenue and Forecast, by Technology (2017-2030)

11.5.4.3. Market Revenue and Forecast, by End User (2017-2030)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Type (2017-2030)

11.5.5.2. Market Revenue and Forecast, by Technology (2017-2030)

11.5.5.3. Market Revenue and Forecast, by End User (2017-2030)

Chapter 12. Company Profiles

12.1. ACM Global Laboratories (US)

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. ARUP Laboratories (US).

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Baylor Esoteric and Molecular Laboratory (US)

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. BioAgilytix Labs (US)

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. BP Diagnostic Centre SDN BHD (Malaysia)

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. BUHLMANN Diagnostics Corp (BDC, US)

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Cerba Xpert (Belgium)

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Eurofins Scientific (Luxembourg)

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Flow Health (US)

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Foundation Medicine (US)

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Buy This Premium Research Report Click Here@ https://www.precedenceresearch.com/checkout/2019

About Us

Precedence Research is a Canada/India based company and one of the leading providers of strategic market insights. We offer executive-level blueprints of markets and solutions beyond flagship surveys. Our repository covers consultation, syndicated market studies, and customized research reports. Through our services we aim at connecting an organization’s goal with lucrative prospects globally.

From gauging investment feasibility to uncovering hidden growth opportunities, our market studies cover in-depth analysis, which also is interspersed with relevant statistics. Recommendation are often enclosed within our reports with the sole intent of enabling organizations achieve mission-critical success.

Contact Us:                  

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

Show More

Janet Edward

I have completed my education in Bachelors in Computer Application. A focused learner having a keen interest in the field of digital marketing, SEO, SMM, and Google Analytics enthusiastic to learn new things along with building leadership skills.

Related Articles

Back to top button